CBRE vs TMDX · P/E 43, rev $21.75B vs P/E 17, rev $363.9M
CBRE Group Inc Class A (CBRE) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the CBRE and TMDX stock pages for the full models.
Not investment advice.